David D. Meek - 18 Jan 2022 Form 4 Insider Report for Entasis Therapeutics Holdings Inc.

Role
Director
Signature
Elizabeth M. Keiley as Attorney-in-Fact for David Meek
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
19 Jan 2022, 15:01:51 UTC
Previous filing
18 Jan 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +27,500 +125% $0.000000 49,500 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service as a director of the Company.